Literature DB >> 7584668

Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].

C J Hu1, O N Ozes, S B Klein, L M Blatt, M W Taylor.   

Abstract

The antiviral activity of human r-metIFN-con1 was compared with that of IFN-alpha 2b and IFN-beta on a number of human, other primate, rodent, feline, and canine cell lines. Although the specific activities of r-metIFN-con1 and IFN-alpha 2b differed 10-fold, the host range was very similar. The host range of IFN-beta differed from that of r-metIFN-con1 and IFN-alpha 2b in that Vero cells were 100-fold better protected by IFN-beta and MDBK protected at a 100-fold less efficiency. In general, there were only minor differences between the host ranges of the three interferons, human and primate cells being better protected than those of other species. However, the tissue of origin of the cell appears to be more important than the species of origin in defining host range [corrected].

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7584668     DOI: 10.1089/jir.1995.15.231

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  4 in total

1.  Consensus interferon used to treat prior partial-responders to pegylated interferon plus ribavirin.

Authors:  Christopher M Moore; Magdalena George; David H Van Thiel
Journal:  Dig Dis Sci       Date:  2011-08-31       Impact factor: 3.199

2.  Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model.

Authors:  Justin G Julander; John D Morrey; Lawrence M Blatt; Kristiina Shafer; Robert W Sidwell
Journal:  Antiviral Res       Date:  2006-09-22       Impact factor: 5.970

3.  Interferon alfacon-1 protects hamsters from lethal pichinde virus infection.

Authors:  Brian B Gowen; Dale L Barnard; Donald F Smee; Min-Hui Wong; Anne M Pace; Kie-Hoon Jung; Scott G Winslow; Kevin W Bailey; Lawrence M Blatt; Robert W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

4.  Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy.

Authors:  J F Zhang; C Hu; Y Geng; J Selm; S B Klein; A Orazi; M W Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.